Skip to main content
Log in

Salmeterol/fluticasone propionate: asthma-related QOL benefits

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Edin HM, Andersen LB, Schoaf L, Scott-Wilson CA, Ho S-Y, Ortega HG.Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. Annals of Allergy, Asthma and Immunology 102: 323-327, No. 4, Apr 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salmeterol/fluticasone propionate: asthma-related QOL benefits. Pharmacoecon. Outcomes News 578, 10 (2009). https://doi.org/10.2165/00151234-200905780-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905780-00023

Keywords

Navigation